This website uses cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.

Scottish partnerships should apply now for share of 7 5m regulatory innovation funding Header Template

‘Scottish partnerships should apply now for share of £7.5m regulatory innovation funding’

4 minutes
Posted: 09-January-2024

InnoScot Health is urging Scottish innovation and science collaborators to take advantage of a £7.5m pot of grant funding available from Innovate UK

Funding applications for up to £50,000 are now being welcomed from organisations who are looking to link up and support the development of new tools, data sets, and approaches that enhance regulatory decision making.

While applications are encouraged from all sectors, specific priority areas in the health and life sciences sector have been set out.

The competition from Innovate UK – part of UK Research and Innovation – aims to “support the development of proposals for virtual networks of expertise in regulation that generate research-based evidence and insights.”

It further aims to support policymaking that “enables agile and proportionate regulation in response to innovation.”

Collaborative networks are expected to:

  • Build evidence bases
  • Strengthen partnerships and knowledge transfer, including plans for working with other networks on cross-cutting themes and challenges
  • Influence policy through research insights that translate evidence into best practice
  • Enhance business capacity to exploit commercial opportunities

The organisation’s Head of Regulatory Affairs, Elaine Gemmell said: “We fully support the aims of this competition from Innovate UK’s Regulatory Science and Innovation Networks programme.

“Indeed, we are currently in the process of gauging interest from other parties.

“By funding up to 30 collaborations, initiatives like these are vital to encouraging collaborative working and serving to ultimately foster better regulatory decision making.

“The programme contributes to the creation of a pro-innovation regulatory environment that benefits society and this competition could be the start of some exciting new ideas which inform future regulatory policy and practice and contribute to better healthcare outcomes for Scottish patients.

“It is important therefore that interested partnerships apply before the end of January in order to be considered.

“Innovate UK believes that by building on existing regulatory science activity, this investment will contribute to securing the UK's position as a global leader in regulatory science.

“If successful in the Discovery phase, they will have the opportunity of developing their proposals with a package of support including workshops and events that will assist in honing their applications for the Implementation phase while encouraging networking between collaborations.”

Network collaborations awarded funding at the Discovery phase will be invited to apply for the Implementation phase competition, which will open on or after August 2024.

Primarily, Innovate UK wants the competition’s collaborative drive for improvement to be targeted across product lifecycles – particularly areas such as approvals, ongoing safety, and performance monitoring – while supporting policymaking.

Elaine added: “It is also great to see the focus here on equality, diversity, and inclusion, including the recognition that diversity contributes to enhanced innovation and ultimately, commercial success.”

Total grant funding requests for the Discovery phase must be no more than £50,000. The competition closes on Wednesday 31 January 2024 at 11am.

The InnoScot Health team offers skilled regulatory experts, dispensing advice and support to healthcare innovators across Scotland, while facilitating and underlining the country’s reputation as a centre of excellence for medical device innovation. The organisation also operates an ISO 13485:2016 quality management system harmonised to the Medical Device Directive.

With more than 20 years’ experience in medical device development, Elaine Gemmell – recently awarded the title of Honorary Professor in the School of Engineering and Physical Sciences at Heriot-Watt University – is a certified ISO 13485/ISO 9001 Lead Auditor and has experience of regulatory approval and CE marking for medical devices.

We Conform

Complying with medical device regulation

InnoScot Health offers a skilled team of regulatory experts. The organisation also operates an ISO 13485:2016 quality management system harmonised to the Medical Device Directive.


Consultancy, training and advice is available to all NHS health boards, plus companies or universities working in partnership with NHS Scotland to develop medical devices. We ensure awareness and compliance with legal responsibilities and support the design and development of products under an accredited regulatory framework.

TwitterLinkedInYoutube

© Copyright 2024, InnoScot Health.

All rights reserved.

InnoScot Health works in partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. Registered Number: SC 236303. Registered address: 272 Bath Street, Glasgow, G2 4JR
Office Address / Deliveries: Suite 203, The Pentagon Centre, 36 Washington Street, Glasgow, G3 8AZ

CSOGJNHNHSBSI

Chat